#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3281306	Functional	Antitumor activity against rat Walker 256 cells intramuscularly allografted in rat assessed as survival rate at 6.25 mg/kg, qd administered for 5 days	Rattus norvegicus	2	ALA3272018	organism-based format	Scientific Literature
2.	ALA3281307	Functional	Antitumor activity against rat Walker 256 cells intramuscularly allografted in rat assessed as survival rate at 3.12 mg/kg, qd administered for 5 days	Rattus norvegicus	2	ALA3272018	organism-based format	Scientific Literature
3.	ALA3281308	Functional	Antitumor activity against rat Walker 256 cells intramuscularly allografted in rat assessed as survival rate at 1.56 mg/kg, qd administered for 5 days	Rattus norvegicus	2	ALA3272018	organism-based format	Scientific Literature
4.	ALA3281309	Functional	Antitumor activity against rat Walker 256 cells intramuscularly allografted in rat assessed as survival rate at 0.78 mg/kg, qd administered for 5 days	Rattus norvegicus	2	ALA3272018	organism-based format	Scientific Literature
5.	ALA3281310	Functional	In vivo antitumor activity against mouse L1210 cells in prognostic scoring system assessed as survival rate at 5 mg/kg, qd administered for 9 days	Mus musculus	1	ALA3272018	organism-based format	Scientific Literature
6.	ALA3281311	Functional	In vivo antitumor activity against mouse L1210 cells in prognostic scoring system assessed as survival rate at 3 mg/kg, qd administered for 9 days	Mus musculus	1	ALA3272018	organism-based format	Scientific Literature
7.	ALA3281453	Functional	In vivo antitumor activity against mouse L1210 cells in prognostic scoring system assessed as survival rate at 1.8 mg/kg, qd administered for 9 days	Mus musculus	1	ALA3272018	organism-based format	Scientific Literature
8.	ALA3281454	Functional	In vivo antitumor activity against mouse L1210 cells in prognostic scoring system assessed as survival rate at 1 mg/kg, qd administered for 9 days	Mus musculus	1	ALA3272018	organism-based format	Scientific Literature
9.	ALA3279196	Toxicity	Toxicity in rat allografted with rat Walker 256 cells intramuscularly assessed as change in body weight at 6.25 mg/kg, qd administered for 5 days	Rattus norvegicus	2	ALA3272018	organism-based format	Scientific Literature
10.	ALA3279197	Toxicity	Toxicity in rat allografted with rat Walker 256 cells intramuscularly assessed as change in body weight at 3.12 mg/kg, qd administered for 5 days	Rattus norvegicus	2	ALA3272018	organism-based format	Scientific Literature
11.	ALA3279198	Toxicity	Toxicity in rat allografted with rat Walker 256 cells intramuscularly assessed as change in body weight at 1.56 mg/kg, qd administered for 5 days	Rattus norvegicus	2	ALA3272018	organism-based format	Scientific Literature
12.	ALA3279199	Toxicity	Toxicity in rat allografted with rat Walker 256 cells intramuscularly assessed as change in body weight at 0.78 mg/kg, qd administered for 5 days	Rattus norvegicus	2	ALA3272018	organism-based format	Scientific Literature
13.	ALA3279764	Functional	Antitumor activity against rat Walker 256 cells intramuscularly allografted in rat assessed as tumor growth inhibition at 6.25 mg/kg, qd administered for 5 days relative to control	Rattus norvegicus	2	ALA3272018	organism-based format	Scientific Literature
14.	ALA3279765	Functional	Antitumor activity against rat Walker 256 cells intramuscularly allografted in rat assessed as tumor growth inhibition at 3.12 mg/kg, qd administered for 5 days relative to control	Rattus norvegicus	2	ALA3272018	organism-based format	Scientific Literature
15.	ALA3279766	Functional	Antitumor activity against rat Walker 256 cells intramuscularly allografted in rat assessed as tumor growth inhibition at 1.56 mg/kg, qd administered for 5 days relative to control	Rattus norvegicus	2	ALA3272018	organism-based format	Scientific Literature
16.	ALA3285941	Functional	Antitumor activity against rat Walker 256 cells intramuscularly allografted in rat assessed as tumor growth inhibition at 0.78 mg/kg, qd administered for 5 days relative to control	Rattus norvegicus	2	ALA3272018	organism-based format	Scientific Literature
17.	ALA3285942	Functional	In vivo antitumor activity against mouse L1210 cells in prognostic scoring system assessed as tumor growth inhibition at 5 mg/kg, qd administered for 9 days relative to control	Mus musculus	1	ALA3272018	organism-based format	Scientific Literature
18.	ALA3285943	Functional	In vivo antitumor activity against mouse L1210 cells in prognostic scoring system assessed as tumor growth inhibition at 3 mg/kg, qd administered for 9 days relative to control	Mus musculus	1	ALA3272018	organism-based format	Scientific Literature
19.	ALA3285944	Functional	In vivo antitumor activity against mouse L1210 cells in prognostic scoring system assessed as tumor growth inhibition at 1.8 mg/kg, qd administered for 9 days relative to control	Mus musculus	1	ALA3272018	organism-based format	Scientific Literature
20.	ALA3285945	Functional	In vivo antitumor activity against mouse L1210 cells in prognostic scoring system assessed as tumor growth inhibition at 1 mg/kg, qd administered for 9 days relative to control	Mus musculus	1	ALA3272018	organism-based format	Scientific Literature